Behavioral and neurochemical effects induced by subchronic l-deprenyl administration

被引:14
作者
Molinengo, L
Ghi, P
机构
[1] Dipartimento di Anatomia, Farmacologia e Medicina Legale, Sezione di Farmacologia, Torino
关键词
deprenyl; memory retention; staircase maze; neurochemical effects;
D O I
10.1016/S0091-3057(97)00001-4
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Deprenyl was administered orally to rats for 15 days. In the staircase maze, a reduction of incorrect responses was observed at 0.9 mg/kg/day; higher or lower doses (3.5 or 0.35 mg/kg/day) were ineffective. In the same range of doses, the subchronic administration of(-)deprenyl did not modify the levels of norepinephrine, 5-hydroxytryptamine, 5-hydroxyindolacetic acid or the density and affinity of alpha-noradrenergic receptors in the cortex, olfactory system, hippocampus and striatum. An increase of the dopamine and a reduction of dihydroxyphenylacetic acid levels was observed only at the highest tested doses, at which no behavioral modification was observed. Only at 1.0 mg/kg/day did (-)deprenyl increase the acetylcholine (ACh) levels in the olfactory system, hippocampus and striatum. This neurochemical effect may be correlated to the behavioral effect observed in the same range of doses. We propose that this increase of ACh levels is determined by an activation of dopaminergic systems, resulting from the increase in the levels of PE caused by the inhibition of monoamine oxidase B (MAO-B) by (-)deprenyl. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:649 / 655
页数:7
相关论文
共 27 条
[11]  
HEINONEN EH, 1989, ACTA NEUROL SCAND, V80, P83
[12]   LIQUID-CHROMATOGRAPHIC ANALYSIS OF CATECHOLAMINES ROUTINE ASSAY FOR REGIONAL BRAIN MAPPING [J].
KELLER, R ;
OKE, A ;
MEFFORD, I ;
ADAMS, RN .
LIFE SCIENCES, 1976, 19 (07) :995-1003
[13]   ENHANCED CATECHOLAMINERGIC AND SEROTONINERGIC ACTIVITY IN RAT-BRAIN FROM WEANING TO SEXUAL MATURITY - RATIONALE FOR PROPHYLACTIC (-)DEPRENYL (SELEGILINE) MEDICATION [J].
KNOLL, J ;
MIKLYA, I .
LIFE SCIENCES, 1995, 56 (08) :611-620
[14]   THE PHARMACOLOGY OF SELEGILINE ((-)DEPRENYL) - NEW ASPECTS [J].
KNOLL, J .
ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 :83-91
[15]  
Knoll J, 1987, J Neural Transm Suppl, V25, P45
[16]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[17]   EFFECTS OF A MAO-B INHIBITOR IN THE TREATMENT OF ALZHEIMER-DISEASE [J].
MANGONI, A ;
GRASSI, MP ;
FRATTOLA, L ;
PIOLTI, R ;
BASSI, S ;
MOTTA, A ;
MARCONE, A ;
SMIRNE, S .
EUROPEAN NEUROLOGY, 1991, 31 (02) :100-107
[18]   PARKINSONS-DISEASE [J].
MARSDEN, CD .
LANCET, 1990, 335 (8695) :948-952
[19]   ACTION OF CAFFEINE, L-PIA AND THEIR COMBINATION ON MEMORY RETENTION IN THE RAT [J].
MOLINENGO, L ;
SCORDO, I ;
PASTORELLO, B .
LIFE SCIENCES, 1994, 54 (17) :1247-1250
[20]   THE ACTION OF ARECOLINE ON RETRIEVAL AND MEMORY STORAGE EVALUATED IN THE STAIRCASE MAZE [J].
MOLINENGO, L ;
ORSETTI, M ;
PASTORELLO, B ;
SCORDO, I ;
GHI, P .
NEUROBIOLOGY OF LEARNING AND MEMORY, 1995, 63 (02) :167-173